Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Wnt ligand inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H30ClN7 |
InChIKeyCWLIDIXROOHEDP-UHFFFAOYSA-N |
CAS Registry2665700-58-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CH | 01 Oct 2021 |